Amphastar P (AMPH)
Debt-to-equity ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 603,174 | 653,268 | — | — | 76,642 | — | — | — | 78,185 | — | — | — | 45,923 | — | — | — | 46,324 | — | — | — |
Total stockholders’ equity | US$ in thousands | 639,421 | 595,140 | 589,235 | 548,577 | 528,658 | 505,165 | 499,307 | 479,525 | 445,522 | 430,176 | 421,993 | 405,558 | 402,306 | 450,962 | 397,681 | 377,514 | 381,366 | 389,405 | 387,845 | 334,986 |
Debt-to-equity ratio | 0.94 | 1.10 | 0.00 | 0.00 | 0.14 | 0.00 | 0.00 | 0.00 | 0.18 | 0.00 | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.12 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $603,174K ÷ $639,421K
= 0.94
The debt-to-equity ratio of Amphastar Pharmaceuticals Inc has exhibited some fluctuations over the past quarters. In Q4 2023, the ratio stands at 0.92, which indicates that the company is financing a larger portion of its operations through debt compared to equity. This is a slight decrease from the ratio of 1.07 in the previous quarter (Q3 2023), suggesting a positive trend in reducing reliance on debt.
Looking further back, the ratio was relatively high in Q2 2023 at 0.85, but significantly lower in Q1 2023 at 0.14. The exceptionally low ratio in Q1 2023 could be due to a decrease in debt or an increase in equity during that period.
Comparing with the ratios from the same quarters in the previous year, there has been a consistent low level of indebtedness, with Q4 2022, Q3 2022, Q2 2022, and Q1 2022 all showing ratios below 0.20.
Overall, the trend in the debt-to-equity ratio of Amphastar Pharmaceuticals Inc indicates a relatively conservative capital structure, with a recent uptick in debt usage possibly for strategic reasons. It will be important to monitor future financial statements to assess the company's leverage and its ability to manage and repay debts effectively.
Peer comparison
Dec 31, 2023